139 related articles for article (PubMed ID: 17724471)
61. Familial Esophageal Squamous Cell Carcinoma with damaging rare/germline mutations in KCNJ12/KCNJ18 and GPRIN2 genes.
Khalilipour N; Baranova A; Jebelli A; Heravi-Moussavi A; Bruskin S; Abbaszadegan MR
Cancer Genet; 2018 Feb; 221():46-52. PubMed ID: 29405996
[TBL] [Abstract][Full Text] [Related]
62. BRCA2 variant aerodigestive cancer risk.
Gruber K
Lancet Oncol; 2015 May; 16(5):e204. PubMed ID: 25869530
[No Abstract] [Full Text] [Related]
63. Genome annotation by shotgun inactivation of a native gene in hemizygous cells: application to BRCA2 with implication of hypomorphic variants.
Ghosh S; Bhunia AK; Paun BC; Gilbert SF; Dhru U; Patel K; Kern SE
Hum Mutat; 2015 Feb; 36(2):260-9. PubMed ID: 25451944
[TBL] [Abstract][Full Text] [Related]
64. Comprehensive Study of Germline Mutations and Double-Hit Events in Esophageal Squamous Cell Cancer.
Zeng B; Huang P; Du P; Sun X; Huang X; Fang X; Li L
Front Oncol; 2021; 11():637431. PubMed ID: 33889545
[TBL] [Abstract][Full Text] [Related]
65. The association between FANCD1/BRCA2 mutations and leukaemia.
Alter BP
Br J Haematol; 2006 May; 133(4):446-8; author reply 448. PubMed ID: 16643458
[No Abstract] [Full Text] [Related]
66. Miscues on the "lack of MEF2A mutations" in coronary artery disease.
Wang Q; Rao S; Topol EJ
J Clin Invest; 2005 Jun; 115(6):1399-400; author reply 1400-1. PubMed ID: 15931371
[No Abstract] [Full Text] [Related]
67. BRCA2-branching out too?
Spitz MR; Liu Y; Amos CI
J Natl Cancer Inst; 2015 May; 107(5):. PubMed ID: 25838449
[No Abstract] [Full Text] [Related]
68. Smokers with gene defect have higher risk of developing lung cancer.
Kmietowicz Z
BMJ; 2014 Jun; 348():g3621. PubMed ID: 24889359
[No Abstract] [Full Text] [Related]
69. Cohort Profile: The Golestan Cohort Study--a prospective study of oesophageal cancer in northern Iran.
Pourshams A; Khademi H; Malekshah AF; Islami F; Nouraei M; Sadjadi AR; Jafari E; Rakhshani N; Salahi R; Semnani S; Kamangar F; Abnet CC; Ponder B; Day N; Dawsey SM; Boffetta P; Malekzadeh R
Int J Epidemiol; 2010 Feb; 39(1):52-9. PubMed ID: 19332502
[No Abstract] [Full Text] [Related]
70. Unfurling the Genetic Map of Sarcomas.
Cancer Discov; 2016 Oct; 6(10):1073-1074. PubMed ID: 27554610
[TBL] [Abstract][Full Text] [Related]
71. A pathogenic germline
Correa T; Laux DE; Hoffman HT
Clin Case Rep; 2021 Jan; 9(1):429-432. PubMed ID: 33489192
[TBL] [Abstract][Full Text] [Related]
72. The Weight of Inevitability-My Journey With BRCA2.
Wu KP
JAMA Oncol; 2023 Nov; 9(11):1497-1498. PubMed ID: 37707838
[TBL] [Abstract][Full Text] [Related]
73. Identification of a Variety of Mutations in Cancer Predisposition Genes in Patients With Suspected Lynch Syndrome.
Yurgelun MB; Allen B; Kaldate RR; Bowles KR; Judkins T; Kaushik P; Roa BB; Wenstrup RJ; Hartman AR; Syngal S
Gastroenterology; 2015 Sep; 149(3):604-13.e20. PubMed ID: 25980754
[TBL] [Abstract][Full Text] [Related]
74. BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers.
Meeks HD; Song H; Michailidou K; Bolla MK; Dennis J; Wang Q; Barrowdale D; Frost D; ; McGuffog L; Ellis S; Feng B; Buys SS; Hopper JL; Southey MC; Tesoriero A; ; James PA; Bruinsma F; Campbell IG; ; Broeks A; Schmidt MK; Hogervorst FB; ; Beckman MW; Fasching PA; Fletcher O; Johnson N; Sawyer EJ; Riboli E; Banerjee S; Menon U; Tomlinson I; Burwinkel B; Hamann U; Marme F; Rudolph A; Janavicius R; Tihomirova L; Tung N; Garber J; Cramer D; Terry KL; Poole EM; Tworoger SS; Dorfling CM; van Rensburg EJ; Godwin AK; Guénel P; Truong T; ; Stoppa-Lyonnet D; Damiola F; Mazoyer S; Sinilnikova OM; Isaacs C; Maugard C; Bojesen SE; Flyger H; Gerdes AM; Hansen TV; Jensen A; Kjaer SK; Hogdall C; Hogdall E; Pedersen IS; Thomassen M; Benitez J; González-Neira A; Osorio A; Hoya Mde L; Segura PP; Diez O; Lazaro C; Brunet J; Anton-Culver H; Eunjung L; John EM; Neuhausen SL; Ding YC; Castillo D; Weitzel JN; Ganz PA; Nussbaum RL; Chan SB; Karlan BY; Lester J; Wu A; Gayther S; Ramus SJ; Sieh W; Whittermore AS; Monteiro AN; Phelan CM; Terry MB; Piedmonte M; Offit K; Robson M; Levine D; Moysich KB; Cannioto R; Olson SH; Daly MB; Nathanson KL; Domchek SM; Lu KH; Liang D; Hildebrant MA; Ness R; Modugno F; Pearce L; Goodman MT; Thompson PJ; Brenner H; Butterbach K; Meindl A; Hahnen E; Wappenschmidt B; Brauch H; Brüning T; Blomqvist C; Khan S; Nevanlinna H; Pelttari LM; Aittomäki K; Butzow R; Bogdanova NV; Dörk T; Lindblom A; Margolin S; Rantala J; Kosma VM; Mannermaa A; Lambrechts D; Neven P; Claes KB; Maerken TV; Chang-Claude J; Flesch-Janys D; Heitz F; Varon-Mateeva R; Peterlongo P; Radice P; Viel A; Barile M; Peissel B; Manoukian S; Montagna M; Oliani C; Peixoto A; Teixeira MR; Collavoli A; Hallberg E; Olson JE; Goode EL; Hart SN; Shimelis H; Cunningham JM; Giles GG; Milne RL; Healey S; Tucker K; Haiman CA; Henderson BE; Goldberg MS; Tischkowitz M; Simard J; Soucy P; Eccles DM; Le N; Borresen-Dale AL; Kristensen V; Salvesen HB; Bjorge L; Bandera EV; Risch H; Zheng W; Beeghly-Fadiel A; Cai H; Pylkäs K; Tollenaar RA; Ouweland AM; Andrulis IL; Knight JA; ; Narod S; Devilee P; Winqvist R; Figueroa J; Greene MH; Mai PL; Loud JT; García-Closas M; Schoemaker MJ; Czene K; Darabi H; McNeish I; Siddiquil N; Glasspool R; Kwong A; Park SK; Teo SH; Yoon SY; Matsuo K; Hosono S; Woo YL; Gao YT; Foretova L; Singer CF; Rappaport-Feurhauser C; Friedman E; Laitman Y; Rennert G; Imyanitov EN; Hulick PJ; Olopade OI; Senter L; Olah E; Doherty JA; Schildkraut J; Koppert LB; Kiemeney LA; Massuger LF; Cook LS; Pejovic T; Li J; Borg A; Öfverholm A; Rossing MA; Wentzensen N; Henriksson K; Cox A; Cross SS; Pasini BJ; Shah M; Kabisch M; Torres D; Jakubowska A; Lubinski J; Gronwald J; Agnarsson BA; Kupryjanczyk J; Moes-Sosnowska J; Fostira F; Konstantopoulou I; Slager S; Jones M; ; Antoniou AC; Berchuck A; Swerdlow A; Chenevix-Trench G; Dunning AM; Pharoah PD; Hall P; Easton DF; Couch FJ; Spurdle AB; Goldgar DE
J Natl Cancer Inst; 2016 Feb; 108(2):. PubMed ID: 26586665
[TBL] [Abstract][Full Text] [Related]
75. A rare truncating BRCA2 variant and genetic susceptibility to upper aerodigestive tract cancer.
Delahaye-Sourdeix M; Anantharaman D; Timofeeva MN; Gaborieau V; Chabrier A; Vallée MP; Lagiou P; Holcátová I; Richiardi L; Kjaerheim K; Agudo A; Castellsagué X; Macfarlane TV; Barzan L; Canova C; Thakker NS; Conway DI; Znaor A; Healy CM; Ahrens W; Zaridze D; Szeszenia-Dabrowska N; Lissowska J; Fabianova E; Mates IN; Bencko V; Foretova L; Janout V; Curado MP; Koifman S; Menezes A; Wünsch-Filho V; Eluf-Neto J; Boffetta P; Fernández Garrote L; Polesel J; Lener M; Jaworowska E; Lubiński J; Boccia S; Rajkumar T; Samant TA; Mahimkar MB; Matsuo K; Franceschi S; Byrnes G; Brennan P; McKay JD
J Natl Cancer Inst; 2015 May; 107(5):. PubMed ID: 25838448
[TBL] [Abstract][Full Text] [Related]
76. Mutational analysis of BRCA1 and BRCA2 in hereditary breast and ovarian cancer families from Asturias (Northern Spain).
Blay P; Santamaría I; Pitiot AS; Luque M; Alvarado MG; Lastra A; Fernández Y; Paredes A; Freije JM; Balbín M
BMC Cancer; 2013 May; 13():243. PubMed ID: 23683081
[TBL] [Abstract][Full Text] [Related]
77. Next-generation sequencing meets genetic diagnostics: development of a comprehensive workflow for the analysis of BRCA1 and BRCA2 genes.
Feliubadaló L; Lopez-Doriga A; Castellsagué E; del Valle J; Menéndez M; Tornero E; Montes E; Cuesta R; Gómez C; Campos O; Pineda M; González S; Moreno V; Brunet J; Blanco I; Serra E; Capellá G; Lázaro C
Eur J Hum Genet; 2013 Aug; 21(8):864-70. PubMed ID: 23249957
[TBL] [Abstract][Full Text] [Related]
78. Frequent germline mutation in the BRCA2 gene in esophageal squamous cell carcinoma patients from a low-risk Chinese population.
Zhong L; Zhu ZZ; Shen Y; Sun G; Zhao X; Zhang S; Yin X; Zhu J; Xu Z; Zhu G
Asian Pac J Cancer Prev; 2011; 12(7):1771-6. PubMed ID: 22126563
[TBL] [Abstract][Full Text] [Related]
79. Mutations in Fanconi anemia genes and the risk of esophageal cancer.
Akbari MR; Malekzadeh R; Lepage P; Roquis D; Sadjadi AR; Aghcheli K; Yazdanbod A; Shakeri R; Bashiri J; Sotoudeh M; Pourshams A; Ghadirian P; Narod SA
Hum Genet; 2011 May; 129(5):573-82. PubMed ID: 21279724
[TBL] [Abstract][Full Text] [Related]
80. Evaluation of BRCA1 and BRCA2 mutations and risk-prediction models in a typical Asian country (Malaysia) with a relatively low incidence of breast cancer.
Thirthagiri E; Lee SY; Kang P; Lee DS; Toh GT; Selamat S; Yoon SY; Taib NA; Thong MK; Yip CH; Teo SH
Breast Cancer Res; 2008; 10(4):R59. PubMed ID: 18627636
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
